Depression News

NEW ORLEANS – Evidence on the use of cannabis for medical conditions is limited, so clinicians should be cautious when discussing it with patients, Kevin P. Hill, MD, MHS, said at the American Psychiatric Association annual meeting.

Clinilabs Drug Development Corp. announced enrollment has begun in a phase 1/2a clinical trial for the use of CYB003, a novel psilocybin analog that will be evaluated for the treatment of major depressive disorder.

Participation in group-based gardening and art demonstrated measurable improvements in women’s psychosocial health, according to results of a study published in PLOS One.

Patients with inflammatory bowel disease were nine times more likely to develop depression, and their unaffected siblings twice as likely to develop depression, according to a study in the Journal of Gastroenterology and Hepatology.

Those with first-episode psychosis demonstrated more suicidal behavior compared with healthy controls, while perceived stress and emotional abuse were linked to an increase in suicidal ideation and risk, according to a recent study.

Use of a cognitive behavioral therapy-based digital mental health intervention led to significant improvement in anxiety and depression symptoms after 12 weeks, per results of a study published in Journal of Medical Internet Research.

Dextromethorphan-bupropion significantly improved symptoms for those with major depressive disorder compared with bupropion alone and produced minimal adverse effects, according to a study published in American Journal of Psychiatry.

Analyzing clinical phenotypes of race, ethnicity and sex, as well as history of concussions and depression, were crucial in determining risk for suicide attempts among youth in the United States, a study showed in JAMA Network Open.

More than 76% of parents of middle and high school students in New Jersey said that depression screenings in school are necessary, according to a survey conducted by Rutgers University.

Enrollment in a workplace mental health program was linked to improvements in symptoms of anxiety and depression and resulted in positive return on investment for employers, according to a study published in JAMA Network Open.